Activ Surgical
Generated 5/10/2026
Executive Summary
Activ Surgical, founded in 2017 and headquartered in Boston, is a privately held medical technology company developing intraoperative surgical intelligence solutions. The company's core mission is to reduce surgical complication rates by providing surgeons with real-time visual insights that reveal critical physiological structures, such as blood flow, which are invisible to the naked eye during procedures. By enhancing visualization and decision-making in the operating room, Activ Surgical aims to improve patient outcomes and reduce the incidence of complications like tissue damage and blood loss. The company's platform leverages advanced imaging and computational algorithms to deliver actionable information without disrupting surgical workflows. Though still in a relatively early stage, Activ Surgical has the potential to address significant unmet needs in minimally invasive surgery, where depth perception and subtle tissue characteristics are often obscured. The company's technology could become a standard adjunct in operating rooms, particularly in complex laparoscopic and robotic surgeries. Given the growing adoption of digital health tools and the increasing focus on surgical safety, Activ Surgical is well-positioned to capture value in the evolving operating room ecosystem. However, the technology requires regulatory clearance and clinical validation, which remain key milestones for commercial success.
Upcoming Catalysts (preview)
- 2026Series A Funding Announcement75% success
- 2027FDA 510(k) Clearance for Core Platform60% success
- 2026Strategic Partnership with Major Surgical Robot Manufacturer50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)